- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 03.07. | ASCO 2025 - bringing a sense of urgency to the war against cancer | ||
| 02.07. | CHMP recommends tablet formulation of BeOne's targeted cancer drug Brukinsa | ||
| 02.07. | The Considered appoints Rob Fuller as chief strategy officer | ||
| 02.07. | Traitorous doubts | ||
| 01.07. | UCB shares promising results for fenfluramine in ultra-rare form of epilepsy | ||
| 01.07. | Avalere Health appoints Jocelyn Crouch as head of brand strategy | ||
| 01.07. | Why tariffs could fuel a new era of domestic pharma manufacturing | ||
| 30.06. | FDA approves Sobi's Gamifant to treat severe inflammatory arthritis complication | ||
| 30.06. | Inizio Evoke appoints Kelly Cusumano as executive vice president, growth and client innovation | ||
| 30.06. | DCODE: your gateway to accelerating local innovation adoption in the UK | ||
| 27.06. | Novartis and ProFound enter cardiovascular disease collaboration worth $750m per target | ||
| 27.06. | Sanofi's Sarclisa recommended by CHMP for new multiple myeloma indication | ||
| 27.06. | Pfizer shares positive phase 3 results for haemophilia A and B therapy Hympavzi | ||
| 27.06. | Winning commercial's AI race with connected CRM and data | ||
| 26.06. | Gilead Sciences and Kymera enter oncology partnership worth up to $750m | ||
| 26.06. | MHRA approves Accord Healthcare's Hetronifly to treat aggressive form of lung cancer | ||
| 26.06. | Ipsen receives CHMP recommendation for Cabometyx in neuroendocrine tumours | ||
| 26.06. | The Considered appoints Emily Knight-Kristoffersen as chief creative officer | ||
| 26.06. | More than digital: prioritising the human element in HCP engagement design | ||
| 25.06. | MHRA becomes founding member of HealthAI Global Regulatory Network | ||
| 25.06. | J&J's Darzalex recommended by CHMP to treat smouldering multiple myeloma | ||
| 25.06. | EC approves argenx's subcutaneous Vyvgart for rare autoimmune disease CIPD | ||
| 25.06. | The value of Medscape Extend - redefining omnichannel engagement with physicians in Europe | ||
| 24.06. | AstraZeneca/Daiichi Sankyo's Datroway granted FDA accelerated approval for lung cancer | ||
| 24.06. | Eli Lilly shares promising phase 3 results for once-weekly insulin candidate efsitora alfa |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .